INSIGHTS ON DRUG DEVELOPMENT

• Organ-On-A-Chip Technology Unlocks Patient-Derived Precision Medicine

  Personalized medicine struggles with models that fail to reflect real human biology. Organ-on-a-Chip systems recreate tissue complexity, helping predict patient-specific treatment responses.

• Characterizing Binding Interactions By ITC

  Isothermal Titration Calorimetry is a powerful technique for analyzing biochemical binding events, which is crucial for understanding molecular interactions and enzyme kinetics in biomedical research.

• The Simplest, Most Powerful Digital PCR Workflow Family

  Scalable digital PCR provides high-throughput automation for up to 384 samples. Support seven-color multiplexing and 3D data analysis to achieve superior sensitivity and streamlined laboratory workflows.

• Faster Clones, Simpler Process: What's Changing In CHO Expression?

  This presentation examines how enhanced glutamine synthetase selection stringency, combined with a high-strength gene promoter, provides greater control over gene expression and supports CHO cell line development.

• Highly Sensitive ELISAs In 90 Minutes

  9/11/2024

  Traditional ELISA methods are often limited by their relatively low throughput and need for multiple wash steps. Learn about a solution that overcomes these challenges and provides rapid results.

• Walk-Away Monitoring Of Cytotoxicity, Viability, And Apoptosis

  10/29/2025

  Real-time cell health monitoring reveals how drug dose and timing impact apoptosis, necrosis, and viability. Explore how automated workflows help pinpoint mechanistic toxicity windows.

• Payload-Linker CMC Services High-Potency R&D And GMP Manufacturing

  6/11/2026

  A closer look at how advanced containment, continuous processing, and integrated CMC workflows help address payload–linker challenges, improve safety, and enable scale-up of antibody–drug conjugates.

• Softgel Formulation Strategies For Challenging Oral Compounds

  6/19/2026

  Explore strategies to solve solubility and permeability challenges, boost oral bioavailability, and ensure consistent absorption — reducing risk and unlocking complex molecules.

• R&D Excellence at Asymchem's UK Facility

  3/12/2026

  Dave Henderson outlines R&D excellence at a UK facility, highlighting integrated labs, advanced experimentation, expert teams, and seamless progression from discovery through scale-up and manufacturing.